Chinese gene sequencing giant BGI Genomics Co., Ltd. today completed an initial public offering on the ChiNext board in Shenzhen, raising around RMB1.7 billion (US$250 million). The successful IPO comes after the company previously failed to list in the U.S. and Hong Kong, as well as an unsuccessful bit to achieve an A-share float via a reverse merger.
iCarbonX, an artificial intelligence-enabled health data mining start-up in China, has participated in a US$8.4 million series B financing round in U.S. healthcare company HealthLoop, with an eye to integrate the American firm’s patient-generated data to its own data mining efforts.
Shenzhen-based Chinese gene sequencing giant BGI Genomics Co., Ltd is making another try for a listing on the ChiNext board of the Shenzhen Stock Exchange, seeking to raise US$250 million by issuing 40 million new shares, after its previous application was rejected last November.
Think of China as the world’s factory no more. The Middle Kingdom has been rising in technological sophistication at light speed in recent years, fueled by top-down policy encouragement and venture capital funding. Ten years from now the world’s second biggest economy – though China should already be the world’s biggest economy long before that – could well be the leading power in the next exciting tech frontier: artificial intelligence (AI), projects Dr. Kai-Fu Lee, founder of Sinovation Ventures and …
Since an early age, Wang Jun has been fascinated with the fundamental philosophical question: What is life? The ex-CEO of Chinese genome sequencing giant BGI and founder of China’s highest-valued precision health start-up iCarbonX now aims to help people answer that question for themselves. Wang entered Peking University, China’s top university, at the age of 16 after achieving the highest college entrance exam score in his hometown of Dongtai county, in Jiangsu province. During the early 1990s, he pursued his …
The IPO application of Chinese genomics powerhouse BGI’s bid to list on the Chi-Next board of the Shenzhen Stock Exchange has been terminated, as Chinese securities regulator cited incomplete documentation as a reason for inability to proceed with its review.
iCarbonX, an artificial intelligence-enabled health data mining start-up backed by Tencent Holdings Ltd. and other investors, has acquired an Israeli image understanding firm Imagu Vision Technologies for an undisclosed amount, the company announced today.
Chinese investors poured a record US$1.1 billion across 21 deals into digital health start-ups, including those in the mobile fitness, patient-doctor communication and online drug store sectors, according to data from CB Insights.
Though deals to private artificial intelligence (AI) companies (excluding incubator and accelerator rounds) fell 10% during the second quarter to 121 transactions, aggregate funding value reached an all-time high of over US$1 billion, thanks to three mega-rounds including a US$154 million series A round in Shenzhen-based healthcare startup iCarbonX.
China Bridge Capital, a financial services firm closely linked to adventurous Chinese Internet company LeEco, has invested RMB300 million (US$45 million) in artificial intelligence-enabled health data mining start-up iCarbonX.
Human bodies can live up to 250 years. Afterwards, brains can be transferred to computers, allowing eternal life in a digital heaven. And this will happen during your lifetime.
Tencent Holdings Ltd. has led a RMB1 billion (US$155 million) series A funding round in artificial intelligence-enabled health data mining start-up iCarbonX, according to the company’s founder quoted by Chinese media.
An artificial intelligence-enabled health data mining start-up, established six months ago by former chief executive of genome sequencing giant Beijing Genomic Institute (BGI), is raising RMB700 million (US$106 million) series A round at a valuation of RMB5 billion (US$760 million).